Benchmarks for Interpretation of Score Differences on the SF-36 Health Survey for Patients with Diabetes
Authors:
- Jakob B. BjornerJBJakob B. Bjorner
- Michael Lyng WoldenMWMichael Lyng Wolden
- Jens GundgaardJGJens Gundgaard
- Kate A. MillerKMKate A. Miller
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Value in Health
- Vol. 16 (6) , 993-1000
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 16 references indexed in Scilit:
- Self-perceived quality of life predicts mortality risk better than a multi-biomarker panel, but the combination of both does bestBMC Medical Research Methodology, 2011
- Published norms underestimate the health-related quality of life among persons with type 2 diabetesJournal of Clinical Epidemiology, 2011
- Not all roads lead to Rome—a review of quality of life measurement in adults with diabetesDiabetic Medicine, 2009
- The Effects of Interventions on Health-Related Quality of Life Among Persons With DiabetesMedical Care, 2007
- Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important differenceCurrent Medical Research and Opinion, 2007
- Using the SF-12 Health Status Measure to Improve Predictions of Medical ExpendituresMedical Care, 2006
- Methods to Explain the Clinical Significance of Health Status MeasuresMayo Clinic Proceedings, 2002
- Health-Related Quality of Life Measurement in Type 2 DiabetesValue in Health, 2000
- Checking the Cox model with cumulative sums of martingale-based residualsBiometrika, 1993
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974